Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021:37:1469-1474.
doi: 10.1016/j.matpr.2020.07.103. Epub 2020 Aug 9.

Nanomaterial assisted bulk scale synthesis of 2-methyl-6-nitroquinoline

Affiliations

Nanomaterial assisted bulk scale synthesis of 2-methyl-6-nitroquinoline

M Chandrappa et al. Mater Today Proc. 2021.

Abstract

Quinolines are an interesting class of moieties with various medicinal chemistry uses. The most prominent is their ability to be used as the last line of therapy for bacterial and viral infections including recent COVID-19. The synthesis of quinoline is through a cyclization reaction and overall reaction yields are about 20%. The bulky ring and the associated crowding of functional groups limit the catalyst options. In this publication, the use of Fe3O4@SiO2 for enhancing yield improvements, especially for heterocyclics is reported. The use of the 40 nm sized silica functionalized magnetite nanoparticles seems to help in both condensation and cyclization steps of representative 2-methyl-6-nitroquinoline. Reaction time reduction due to surface enabled catalysis of nanoparticles is 110 min to 80 min. The reaction yield has doubled due to the presence of catalyst and the mechanism suggests this drastic result is due to stabilization of unstable intermediate on the acidic surface of the silica coating. This near homogeneous catalysis of 40 nm sized, silica functionalized, magnetite nanoparticles have far reaching applications in bulk drug industry for drugs like chloroquine & hydroxychloroquine, the two essential drugs for prophylactic use for COVID-1.

Keywords: 2-methyl-6-nitroquinolin; Bulk Scale Synthesis; Fe3O4@SiO2; Quinoline; Silica functionalized Magnetic Nanoparticles (SMNP).

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Scheme 1
Scheme 1
Antimalarial quinolone structures a) Cholroquine, b) Amodiaquine, c) Quinine) d) Mefloquine.
Fig. 1
Fig. 1
Diagrammatic representation of Fe3O4@SiO2 Synthesis: Synthesis of nanoparticles using ferrous sulphate heptahydrate, NaNO3 as starting materials and sodium hydroxide as reducing agent. The NaNO3 in equilibrium with FeSO4 generates in situ which allows nanoparticle formation.
Fig. 2
Fig. 2
SEM analysis of silica functionalized magnetic nanoparticles.
Fig. 3
Fig. 3
IR spectra of silica functionalized magnetic nanoparticles of different batches and compared with non-silanized magnetic nanoparticles.
Scheme 2
Scheme 2
Synthesis scheme of quinoline derivative: The conjugative addition, cyclization, and aromatization reactions happened in situ of the reaction.
Scheme 3
Scheme 3
Mechanism for synthesis of 2-methyl-6-nitroquinoline: The reaction mechanism with silica functionalized magnetic nanocatalyst for the synthesis of 2-methyl-6-nitroquinoline.
Fig. 4
Fig. 4
Reduction of reaction time via the Fe3O4@SiO2 catalyst: The graph shows the relation between the reaction yields versus reaction time. This the proof that of Fe3O4@SiO2 catalyst will reduce the reaction and essential improvement in product yield (Green peak). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)

References

    1. Sharma R., Patil S., Maurya P. Drug discovery studies on quinoline-based derivatives as potential antimalarial agents. SAR QSAR Environ. Res. 2014;25:189–203. - PubMed
    1. Ramírez-Prada J., Robledo S.M., Vélez I.D., Crespo M.del P., Quiroga J., Abonia R., Montoya A., Svetaz L., Zacchino S., Insuasty B. Synthesis of novel quinoline–based 4,5–dihydro–1 H –pyrazoles as potential anticancer, antifungal, antibacterial and antiprotozoal agents. Eur. J. Med. Chem. 2017;131:237–254. - PubMed
    1. Xu M., Wagerle T., Long J.K., Lahm G.P., Barry J.D., Smith R.M. Insecticidal quinoline and isoquinoline isoxazolines. Bioorganic Med. Chem. Lett. 2014;24:4026–4030. - PubMed
    1. Ghorab M.M., Alsaid M.S. Anti-breast cancer activity of some novel quinoline derivatives. Acta Pharm. 2015;65:271–283. - PubMed
    1. Paloque L., Verhaeghe P., Casanova M., Castera-Ducros C., Dumètre A., Mbatchi L., Hutter S., Kraiem-M’Rabet M., Laget M., Remusat V., Rault S., Rathelot P., Azas N., Vanelle P. Discovery of a new antileishmanial hit in 8-nitroquinoline series. Eur. J. Med. Chem. 2012;54:75–86. - PubMed

LinkOut - more resources